Download ASCO 2016 Posters and Presentations Schedule

Posters and Presentations ASCO 2016
S A T U R D AY, J U N E 4 , 2 0 1 6
Poster session: Gastrointestinal (Colorectal) Cancer
Comparative molecular analyses of BRAF-V600E mutant
tumors: Colorectal cancers (CRC) vs. melanomas
Time & Location: 8:00-11:30 a.m., Hall A
Abstract Number / Poster Number: #3598 / #295
Presenter: Shelly Ann Christiansen, MD, Georgetown, University
Hospital
Poster session: Gastrointestinal (Colorectal) Cancer
Comparative molecular analyses of colon versus rectal tumors
Time & Location: 8:00-11:30 a.m., Hall A
Abstract Number / Poster Number: #3552 / #249
Presenter: John Marshall, MD, Lombardi Comprehensive Cancer
Center, Georgetown University
Poster session: Gastrointestinal (Colorectal) Cancer
Ras family mutation patterns in a large cohort of CRCs
Time & Location: 8:00-11:30 a.m., Hall A
Abstract Number / Poster Number: #3599 / #296
Presenter: Joanne Xiu, PhD, Caris Life Sciences
Poster session: Gastrointestinal (Noncolorectal) Cancer
Comparative molecular analyses of esophageal cancer:
Adenocarcinoma vs. squamous cell carcinomas and impact
on outcome
Time & Location: 8:00-11:30 a.m., Hall A
Abstract Number / Poster Number: #4035 / #27
Presenter: Mohamed E. Salem, MD, Lombardi Comprehensive
Cancer Center, Georgetown University
Poster session: Gastrointestinal (Noncolorectal) Cancer
Comparative molecular analyses of pancreatic cancer (PC):
KRAS wild type vs. KRAS mutant tumors and primary tumors
vs. distant metastases
Time & Location: 8:00-11:30 a.m., Hall A
Abstract Number / Poster Number: #4121 /#113
Presenter: Mohamed E. Salem, MD, Lombardi Comprehensive
Cancer Center, Georgetown University
Poster session: Central Nervous System Tumors
Comparison of molecular alteration in glioblastoma tumors
from old and young patients
Time & Location: 1:00-4:30 p.m., Hall A
Abstract Number / Poster Number:#2056 / #243
Presenter: Joanne Xiu, PhD, Caris Life Sciences
Poster session: Health Services Research and Quality of Care
Differences in the molecular landscape of cancer between
African American (AA) and Caucasian (CC) cancer patients
Time & Location: 1:00-4:30 p.m., Hall A
Abstract Number / Poster Number: #6558 / #45
Presenter: Elisabeth I. Heath, MD, Karmanos Cancer Institute,
Wayne State University
Poster session: Genitourinary (Prostate) Cancer
Use of panomic assessment to reveal DNA repair alterations
and to predict potential therapeutic response to taxaneplatinum combination therapy in prostate cancer
Time & Location: 1:00-4:30 p.m., Hall A
Abstract Number / Poster Number: #5040/ #297
Presenter: Nancy Ann Dawson, MD, Lombardi Comprehensive
Cancer Center
Poster session: Melanoma/Skin Cancers
Disparity in PD-L1 expression between metastatic uveal
and cutaneous melanoma
Time & Location: 1:00-4:30 p.m., Hall A
Abstract Number / Poster Number: #9541/ #146
Presenter: Asad Javed, MD, Kimmel Cancer Center, Thomas
Jefferson University
Caris Research Institute is a trademark of Caris Life Sciences.
© 2016 Caris Life Sciences. All rights reserved. TN0289 v1 June 1, 2016
S U N D AY, J U N E 5 , 2 0 1 6
Poster session: Breast Cancer – Triple-Negative/Cytotoxics/Local
Therapy
Predictive value of topoisomerase 1 by immunohistochemistry (TOP1 IHC) in patients with metastatic breast cancer
receiving irinotecan-based therapy
Time & Location: 8:00-11:30 a.m., Hall A
Abstract Number / Poster Number: #1037/ #142
Presenter: Nicholas J. Robert, MD, The US Oncology Network
M O N D AY, J U N E 6 , 2 0 1 6
Poster session: Tumor Biology
Distribution of PD-L1 expression in diverse cancer types:
Experience with over 10,000 cases
Time & Location: 1:00-4:30 p.m., Hall A
Abstract Number / Poster Number: #11548/ #245
Presenter: Zoran Gatalica MD, DSc, Caris Life Sciences
Poster session: Tumor Biology
Tumor profiling of liver metastases (LM) from CRC, NSCLC,
pancreatic (PC), breast (BC) and gastroesophageal (GE)
tumors to reveal differences versus primary tumors
including in cMET, MYC, CDK4, Her2, b-catenin and PD1
Time & Location: 1:00-4:30 p.m., Hall A
Abstract Number / Poster Number: #11604/ #301
Presenter: Wafik S. El-Deiry, MD, PhD, Fox Chase Cancer Center
Poster Discussion session: Tumor Biology
Novel panomic validation of time to next treatment (TNT) as
an effective surrogate outcome measure in 4,729 patients
Time & Location: 4:45-6:00 p.m., Hall A, S406
Abstract Number / Poster Number: #11521 / #218
Presenter: John Marshall, MD, Lombardi Comprehensive Cancer
Center, Georgetown University
T U E S D A Y, J U N E 7 , 2 0 1 6
Oral Abstract session: Tumor Biology
Fusion analysis of solid tumors to reveal novel
rearrangements in breast carcinomas
Time & Location: 9:12-9:24 a.m., S100a
Abstract Number / Poster Number: #11504
Presenter: Igor A. Astsaturov, MD, PhD, Fox Chase Cancer Center
To order or learn more, visit www.CarisLifeSciences.com.
US: 888.979.8669 | [email protected]
Intl: 00 41 21 533 53 00 | [email protected]
Caris Research Institute is a trademark of Caris Life Sciences.
© 2016 Caris Life Sciences. All rights reserved. TN0289 v1 June 1, 2016